Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.31% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NKTR · Dec 31, 2025
NEKTAR THERAPEUTICS. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-104547General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-377.52% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-43.89% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
100.00% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-253.66% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
212.43% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
22.90% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.97%
- Current
- 0.31%
- Delta
- -0.66%
- Previous
- -413.58%
- Current
- -377.52%
- Delta
- 36.06%
- Previous
- -51.13%
- Current
- -43.89%
- Delta
- 7.24%
- Previous
- -268.63%
- Current
- -253.66%
- Delta
- 14.97%
- Previous
- 231.15%
- Current
- 212.43%
- Delta
- -18.71%
- Previous
- 26.06%
- Current
- 22.90%
- Delta
- -3.15%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · NKTR Fundamental State →Has State · NEKTAR THERAPEUTICS →Transitioned To · NKTR PROFITABILITY_INCREASED →Transitioned To · NKTR Fundamental State →Transitioned To · NKTR CAPEX_INTENSITY_DECREASED →Transitioned To · NKTR CASH_GENERATION_INCREASED →Transitioned To · NKTR GROWTH_INCREASED →Transitioned To · NKTR R_AND_D_INTENSITY_DECREASED →Transitioned To · NKTR SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.